Probi Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Private

  • Employees
  • 157

Employees

  • Latest Deal Type
  • 2ndary - Open

  • Latest Deal Amount
  • $89.5M

Probi General Information

Description

Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. Its research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific).

Contact Information

Website
www.probi.se
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Ideongatan 1A
  • 223 70 Lund
  • Sweden
+46 046-286
Primary Industry
Other Consumer Non-Durables
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • Ideongatan 1A
  • 223 70 Lund
  • Sweden
+46 046-286

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Probi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Open Market 16-Jan-2025 $89.5M Completed Profitable
7. Merger/Acquisition 01-Jan-2016 Completed Profitable
6. Merger/Acquisition 11-Feb-2014 Cancelled Profitable
5. Secondary Transaction - Private 10-Jan-2014 Completed Profitable
4. Secondary Transaction - Open Market 01-Aug-2012 Completed Profitable
3. Secondary Transaction - Private 07-Sep-2011 Completed Profitable
2. IPO 02-Dec-2004 $8.48M $8.48M Completed Profitable
1. Later Stage VC 30-Jun-2000 Completed Generating Revenue
To view Probi’s complete valuation and funding history, request access »

Probi Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented prob
Other Consumer Non-Durables
Lund, Sweden
157 As of 2024

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Probi Competitors (1)

One of Probi’s competitors is AstraZeneca, a Formerly PE-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Probi Patents

Probi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026017258-A1 Lacticaseibacillus compositions and uses thereof Pending 18-Jul-2024
WO-2026017905-A1 Lacticaseibacillus compositions and uses thereof Pending 18-Jul-2024
AU-2020294892-A1 Lactobacillus compositions and uses thereof Pending 18-Jun-2019
CA-3139619-A1 Lactobacillus compositions and uses thereof Pending 18-Jun-2019
EP-3986433-A1 Lactobacillus compositions and uses thereof Pending 18-Jun-2019 A61K35/747
To view Probi’s complete patent history, request access »

Probi Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Probi Investments & Acquisitions (5)

Probi’s most recent deal was a PIPE with BLIS Technologies for . The deal was made on 06-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BLIS Technologies 06-Jul-2021 PIPE Biotechnology
Vital Nutrients 20-Oct-2020 Corporate Other Consumer Non-Durables
VivaPro 24-Mar-2020 Joint Venture Other Consumer Non-Durables
Nutraceutix 03-Oct-2016 Merger/Acquisition Pharmaceuticals
Probac (IP Rights for Two Thermostable Strains in Lund, Sweden) 11-Mar-2016 Corporate Asset Purchase Buildings and Property
To view Probi’s complete investments and acquisitions history, request access »

Probi ESG

Risk Overview

Risk Rating

Updated October, 31, 2024

28.08 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Biotechnology

Subindustry

of 444

Rank

Percentile

To view Probi’s complete esg history, request access »

Probi Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Nutraceutix Redmond, WA 1984

Probi FAQs

  • When was Probi founded?

    Probi was founded in 1991.

  • Where is Probi headquartered?

    Probi is headquartered in Lund, Sweden.

  • What is the size of Probi?

    Probi has 157 total employees.

  • What industry is Probi in?

    Probi’s primary industry is Other Consumer Non-Durables.

  • Is Probi a private or public company?

    Probi is a Private company.

  • What is Probi’s current revenue?

    The current revenue for Probi is .

  • How much funding has Probi raised over time?

    Probi has raised $8.48M.

  • Who are Probi’s competitors?

    AstraZeneca is a competitor of Probi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process